Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Mar 1;42(2):66-73.
doi: 10.3928/01477447-20190225-02.

The Role of Orthobiologics in the Management of Osteoarthritis and Focal Cartilage Defects

The Role of Orthobiologics in the Management of Osteoarthritis and Focal Cartilage Defects

Benjamin J Sherman et al. Orthopedics. .

Abstract

Individuals with osteoarthritis have a diminished quality of life, and the condition is a major cause of disability. Newer biologic treatments have been developed that are believed to modify disease progression. These predominantly include hyaluronic acid, platelet-rich plasma, bone marrow aspirate concentrate, and adipose-derived mesenchymal stem cells. There is conflicting evidence regarding the use of orthobiologics for osteoarthritis and for focal chondral defects, although most studies indicate that injections of biologics are safe and without significant adverse effects. [Orthopedics. 2019; 42(2):66-73.].

Similar articles

See all similar articles

MeSH terms

LinkOut - more resources

Feedback